Found 41 matching trials
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
PHASE3The main purpose of this study is to evaluate the efficacy and safety of ga...
Status
Active Not Recruiting
Location
Rehabilitation & Neurological Services
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
PHASE3The main purpose of this study is to evaluate the efficacy of the study dru...
Location
Territory Neurology & Research Institute
Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly
N/AObjective: To determine in real life the efficacy, safety and tolerability ...
Location
Campus Bio Medico University Hospital
A Study of Galcanezumab in Healthy Participants.
PHASE1The main purpose of this study is to evaluate how much galcanezumab gets in...
Location
Covance Clinical Research Inc
A Study of Galcanezumab in Participants With Chronic Cluster Headache
PHASE3The main purpose of this study is to evaluate the efficacy of the study dru...
Location
Mayo Clinic Hospital
Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies
N/ABeing able to predict each patients response to a specific treatment can me...
Location
Hospital Clínico Universitario Lozano Blesa
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
PHASE3The main purpose of this study is to evaulate the efficacy and safety of ga...
Status
Active Not Recruiting
Location
Rehabilitation & Neurological Services
A Study of Galcanezumab in Healthy Participants
PHASE1The purposes of this study are:
* To evaluate tolerability of the Galcanez...
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
PHASE3The main purpose of this study is to evaluate the efficacy and safety of th...
Location
21st Century Neurology
Emgality for Migraine in Breastmilk
N/AThe goal of this project is to evaluate galcanezumab transfer into maternal...
Location
University of California, San Francisco